Cargando…
The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma
SIMPLE SUMMARY: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, and it is an increasing factor in the cause of hepatocellular carcinoma (HCC). The incidence of NAFLD has increased in recent decades, accompanied by an increase in the prevalence of other metabolic di...
Autores principales: | Zhang, Chunye, Yang, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345138/ https://www.ncbi.nlm.nih.gov/pubmed/34359642 http://dx.doi.org/10.3390/cancers13153740 |
Ejemplares similares
-
Current Options and Future Directions for NAFLD and NASH Treatment
por: Zhang, Chunye, et al.
Publicado: (2021) -
Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Zhang, Chunye, et al.
Publicado: (2021) -
Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options
por: Zhang, Chunye, et al.
Publicado: (2021) -
Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023) -
NAFLD‐related hepatocellular carcinoma: The growing challenge
por: Shah, Pir Ahmad, et al.
Publicado: (2023)